A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy

Clinical trial NCT05582395 · COMPLETED

Trial details

NCT number: NCT05582395
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiomyopathy, Hypertrophic

Start date: 2022-12-14
Primary completion: 2025-03-06
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.